Amazon launched Bio Discovery platform offering over 40 AI biology models for drug discovery, announced at AWS Life Science Symposium.
Platform integrates wet‑lab partners Ginkgo Bioworks and Twist Bioscience, enabling real‑time cost and turnaround estimates for antibody candidates.
Sloan Kettering validated antibody design workflow on 300,000 targets, generating 100,000 candidates, streamlining model selection and optimization.
Jefferies analysts say the service can accelerate queued projects and allow computational biologists to support more programs.